Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Expression profiling by high throughput sequencing | BED | Jun 26, 2024 | |||||
GSE176493 |
Comprehensive target engagement by EZH2 inhibitor CPI-0209 allows for preferential targeting of ARID1A mutant urothelial carcinoma
|
|
252 |
|
Patrick Trojer | Jun 26, 2024 |